Get started
Author

Yanet Jerez-Barceló

Observed names: Jerez Barceló, Yanet, Yanet Jerez, Yanet Jerez-Barcel
OpenAlex ID: A5027149124
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
2021 · Arturo Chang-Monteagudo, Rolando Ochoa-Azze, et al. · The Lancet Regional Health - Americas · 43
PDF
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
2022 · Rolando Ochoa-Azze, Arturo Chang-Monteagudo, et al. · The Lancet Respiratory Medicine · 27
PDF
A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
2022 · Franciscary Pi-Estopiñan, María Teresa Pérez, et al. · Vaccine · 9
Biomarkers of sequela in adult patients convalescing from COVID-19
2022 · Vianed Marsán-Suárez, Imilla Casado-Hernández, et al. · Advances in Biomarker Sciences and Technology · 1
PDF
SOBERANA®Plus: refuerzo seguro y eficaz de la inmunidad natural preexistente contra SARS-CoV-2
2023 · Verez Bencomo, Vicente, Ochoa Azze, Rolando, et al. · Anales de la Academia de Ciencias de Cuba
Works count: 5
Citation count: 80
H-index: 3
I10-index: 2
Year
Topic
Type